about
50years of oral lipid-based formulations: Provenance, progress and future perspectives.An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration.Retention of alkali, alkaline earth and transition metals on an itaconic acid cation-exchange column. Eluent pH, ionic strength and temperature effects upon selectivity.'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.Non-linear increases in danazol exposure with dose in older vs. younger beagle dogs: the potential role of differences in bile salt concentration, thermodynamic activity, and formulation digestionGel-Mediated Electrospray Assembly of Silica Supraparticles for Sustained Drug DeliveryAn in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulationsRemoval of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in ratsLocal inflammation alters the lung disposition of a drug loaded pegylated liposome after pulmonary dosing to ratsEngineering Biocoatings To Prolong Drug Release from Supraparticles
P50
Q38811050-958D880A-7E5C-4114-881E-8324E4C67FCBQ40113438-5275BDC5-580C-4D1F-A997-3BA51071CEC6Q44116712-E40F16D1-5E0D-46AB-A995-424E4D8EC5FDQ44836606-44FB2F90-016C-422E-AE34-CF6FA5B82357Q47596122-8CF5D13A-189F-46E9-A420-4ABF68194C86Q57152378-D165E9BA-1E71-49D7-8DEE-66714821DE60Q57644601-F76B4BF2-F824-4E8F-965E-B75D554B96A2Q85649182-DDEB345E-A1F5-4820-B7EA-CE78080941BBQ90955807-CE9B5574-7BD3-49FA-8063-0224B8DD62AFQ92455829-419CEB62-09D8-4111-AD74-614EA089EE87Q92615560-DE0E02E6-17A4-4ED1-B4FD-8860E5CDD387
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Orlagh M. Feeney
@ast
Orlagh M. Feeney
@en
Orlagh M. Feeney
@es
Orlagh M. Feeney
@nl
Orlagh M. Feeney
@sl
type
label
Orlagh M. Feeney
@ast
Orlagh M. Feeney
@en
Orlagh M. Feeney
@es
Orlagh M. Feeney
@nl
Orlagh M. Feeney
@sl
prefLabel
Orlagh M. Feeney
@ast
Orlagh M. Feeney
@en
Orlagh M. Feeney
@es
Orlagh M. Feeney
@nl
Orlagh M. Feeney
@sl
P106
P1153
6505765692
P31
P3835
orlagh-feeney
P496
0000-0002-5415-1707